Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cholecystolithiasis × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 107 Gastro-enteropancreatic neuroendocrine tumor 18 Stomach Neoplasms 11 Carcinoma, Neuroendocrine 11 Pancreatic Neoplasms 10 Pheochromocytoma 9 Neoplasms 9 Breast Neoplasms 9 Prostatic Neoplasms 8 Paraganglioma 8 Carcinoma, Hepatocellular 8 Carcinoid Tumor 8 Adenoma, Islet Cell 8 Neoplasm Metastasis 7 Gastrointestinal Neoplasms 7 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Thyroid Neoplasms 6 Sarcoma 5 Rectal Neoplasms 5 Ovarian Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Liver Neoplasms 5 Colonic Neoplasms 5 Carcinoma 5 Uterine Cervical Neoplasms 4 Gastrointestinal Stromal Tumors 4 Central Nervous System Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡